Novartis
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.About NVS
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies.
NVS Key Statistics
NVS News
Novartis (NVS) stock plunged about 13% in Tuesday’s pre-market trading as the Swiss drugmaker’s experimental drug, del-desiran, for a muscle-wasting disorder fa...
Swiss drugmaker Novartis' (NVS) shares fell 13% in premarket trading on Tuesday following news that its late-stage trial for muscle-wasting drug candidate del-d...
Arnd Wiegmann / Reuters Novartis NOVN -3.18 %decrease; down pointing triangle said an experimental drug for neuromuscular disease myotonic dystrophy type 1 did...
Analyst ratings
41%
of 29 ratingsMore NVS News
Novartis NVS announced that the late-stage study on investigational candidate, pelacarsen, failed. Pelacarsen is an investigational antisense oligonucleotide (...
Shares of Amgen AMGN were down 5% in after-hours trading on Friday after Novartis NVS announced that the phase III Lp(a)HORIZON study evaluating the latter’s in...
After Novartis (NVS) reported that pelacarsen’s Phase 3 HORIZON study failed to demonstrate a statistically significant reduction in major adverse cardiovascula...
After Novartis (NVS) announced pelacarsen missed its primary endpoint of reducing cardiovascular events in the Phase 3 HORIZON study, UBS called the news “not g...
Analyst Sachin Jain from Bank of America Securities reiterated a Buy rating on Novartis AG and increased the price target to CHF150.00 from CHF140.00. Sachin Ja...
Shares of Novartis fell in after-hours trading on Friday. Florence Lo / Reuters A highly anticipated cholesterol drug from Novartis NOVN -1.33 %decrease; down...
Novartis ( (NVS) ) has provided an announcement. On September 4, 2026, Novartis reported topline Phase III results from its Lp(a)HORIZON trial evaluating pelac...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.